Analysis of the Persistence, Reservoir and HIV Latency

Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Feb 28, 2023

Keywords

ClinConnect Summary

The APRIL study is a research trial that aims to better understand how HIV persists in the body, even when patients are on treatment. Researchers will collect blood samples from adults who are living with HIV to look at specific cells that can hide the virus. By studying these cells, the team hopes to learn more about why HIV can remain in the body despite antiretroviral therapy, which is the medication used to manage the infection.

To participate in this trial, individuals must be at least 18 years old, have an HIV infection, and be able to provide informed consent. Unfortunately, those who are not infected with HIV, younger than 18, or do not have social insurance cannot take part. While the study is not yet recruiting participants, those who join can expect to provide blood samples and contribute to important research that could help improve HIV treatments in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • HIV-infection
• • Adults (\>18 years)
• • Social insurance
• • Informed consent
• Exclusion Criteria:
• • HIV-uninfected
• • \<18 years
• • Lack of social insurance
• • Lack or withdraw of consent